News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year20272026202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search The HITIHE project concludes with a meeting of all project members in Antwerp 23/10/2023 Vall d'Hebron promotes ReALLNet to promote research in acute lymphoblastic leukaemia 18/10/2023 RBDCOV members meet at Vall d'Hebron to advance the development of BIMERVAX vaccine 11/10/2023 Approved the first specific pill for postpartum depression in the United States 01/09/2023 A trial demostrates the efficacy of an oral drug for the prevention of chronic migraine 22/08/2023 Projects in pediatric hematology and oncology at the Iberian congress of the specialty 26/06/2023 Vall d’Hebron acull una sessió sobre els assaigs clínics en fetge gras no alcohòlicl 24/05/2023 Recruitment for a study on prevention of chronic malnutrition in Angola concludes 10/05/2023 Vall d'Hebron participates in a guide for clinical trials with drug combinations 04/05/2023 62% of children with a ventricular assist device receive a new heart 03/05/2023 New marker enables discontinuation of unnecessary aspirin medicalization during pregnancy 29/03/2023 Vall d’Hebron inclou el primer pacient en un estudi pioner en teràpia CAR-T per al lupus 23/03/2023 clinical trial to evaluate the benefits of physical exercise in elderly people with cancer 01/03/2023 Dr. Lucas Moreno, new president-elect of the group in neuroblastoma in Europe (SIOPEN) 08/02/2023 Vall d'Hebron will develop medicines for children with a 3D printer 31/01/2023 Bufa la Bombolla raises €12,480 for research in primary immunodeficiencies 14/10/2022 ESPID has awarded a study in which Vall d'Hebron has participated 13/06/2022 A publication of Vall d'Hebron, awarded by 'Anales de Pediatría' 02/06/2022 Hepatology is the Service with the highest participation in liver disease trials 22/02/2022 A program to support patients with primary immunodeficiencies at Vall d'Hebron expands to Bellvitge Hospital 19/01/2022 Pagination « First First page ‹ Previous Previous page 1 2 3 4 5 Next › Next page Last » Last page